Cargando…
Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822634/ https://www.ncbi.nlm.nih.gov/pubmed/21362132 http://dx.doi.org/10.1111/j.1582-4934.2011.01295.x |
_version_ | 1782290436487905280 |
---|---|
author | Paz-Ares, Luis Moecks, Joachim Klughammer, Barbara |
author_facet | Paz-Ares, Luis Moecks, Joachim Klughammer, Barbara |
author_sort | Paz-Ares, Luis |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3822634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-38226342015-04-06 Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69) Paz-Ares, Luis Moecks, Joachim Klughammer, Barbara J Cell Mol Med Letter to the Editor Blackwell Publishing Ltd 2011-05 2011-05-26 /pmc/articles/PMC3822634/ /pubmed/21362132 http://dx.doi.org/10.1111/j.1582-4934.2011.01295.x Text en © 2011 F. Hoffmann - La Roche Ltd. Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd |
spellingShingle | Letter to the Editor Paz-Ares, Luis Moecks, Joachim Klughammer, Barbara Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69) |
title | Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69) |
title_full | Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69) |
title_fullStr | Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69) |
title_full_unstemmed | Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69) |
title_short | Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69) |
title_sort | reply to watkins and rukazenkov (j cell mol med 2010), re-letter of response to manuscript entitled ‘clinical outcomes in nsclc patients with egfr mutations: pooled analysis’ (paz-ares et al., j cell mol med. 2010; 14(1–2): 51–69) |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822634/ https://www.ncbi.nlm.nih.gov/pubmed/21362132 http://dx.doi.org/10.1111/j.1582-4934.2011.01295.x |
work_keys_str_mv | AT pazaresluis replytowatkinsandrukazenkovjcellmolmed2010reletterofresponsetomanuscriptentitledclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed201014125169 AT moecksjoachim replytowatkinsandrukazenkovjcellmolmed2010reletterofresponsetomanuscriptentitledclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed201014125169 AT klughammerbarbara replytowatkinsandrukazenkovjcellmolmed2010reletterofresponsetomanuscriptentitledclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed201014125169 |